Gernandt & Danielsson advises JPMorganChase in connection with the financing of ANI Pharmaceuticals’ offer for Egetis Therapeutics
On 5 November 2026, ANI Pharmaceuticals, Inc. announced a recommended public takeover offer to shareholders and holders of convertibles and warrants in Egetis Therapeutics AB.